semaglutide – Dr. Barry Dworkin

Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness. Study authors state that causality is not established. The health benefits of controlling diabetes, reduced heart, liver, kidney, and brain disease need to be considered with its use.

July 4, 2024

Medical Mythbusting Commentary for July 4, 2024 Source:Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness
Sunday House Call, #909, January 14, 2024: How health insurance company wanna-be-doctor bean counter’s medication-coverage decisions interfere with therapeutic management and has had a deleterious effect on (my) patients’ health outcomes.

January 14, 2024

I talked about this before yet this continues to be a major issue in that evidence-based medicine is being thwarted by insurance companies’ decision to not provide Semaglutide (Ozempic) for the treatment and management of obesity. It is having a deleterious effect both from a mental and physical health perspective on my patients. Wasn’t the…
U.S. pharmacies that are compounding unregulated vials of semaglutide for sale during the Ozempic shortage has led to Poison centers reporting a 1,500% increase in calls related to accidental overdose.

December 15, 2023

Medical Mythbusting Commentary for December 15, 2023 Source:Poison centers see nearly 1,500% increase in calls related to injected weight-loss drugs as people accidentally overdose
Obesity drug Wegovy cut risk of serious heart problems by 20 per cent, study finds

November 13, 2023

Medical Mythbusting Commentary for November 13, 2023 Source:Obesity drug Wegovy cut risk of serious heart problems by 20 per cent, study finds Reference:Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Meta-analyses of randomized controlled trials looks at efficacy of semaglutide (Ozempic) in treating people suffering with obesity

December 19, 2022

Medical Mythbusting Commentary for December 19, 2022 Source:Efficacy of Semaglutide in Treating Obesity: A Systematic Review of Randomized Controlled Trials (RCTs)
Diabetes drug in short supply in U.S. (but not in Canada) after celebrities, influencers touted its weight-loss benefits.

December 15, 2022

Medical Mythbusting Commentary for December 15, 2022 Source:Diabetes drug in short supply in U.S. after celebrities, influencers touted its weight-loss benefits
Wegovy (semaglutide) approved by FDA to support people struggling to lose weight (and that includes many). Health Canada did so in November 2021. Major addition to weight-loss management options.

June 8, 2022

Medical Mythbusting Commentary for June 8, 2022 Source:Weight-loss drug called Wegovy receives FDA approval
Treatments for weight loss do exist, work well for many, and reveal our growing understanding of how our homeostatic, motivational, and executive brain centers interact with respect to weight control.

May 11, 2022

Medical Mythbusting Commentary for May 11, 2022 Source:People Taking New Hunger-Blocking Drug Lose 24 Kilograms On Average
Sunday House Call, #815, November 14, 2021: @YoniFreedhoff discusses “2021’s dumbest scientifically published exercise recommendation for the treatment of obesity” and what works in reality.

November 14, 2021

Topics today include: 2021’s Dumbest Scientifically Published Exercise Recommendation For The Treatment Of Obesity The tremendous success of the HPV vaccines. Cervical cancer and HPV infections have significantly decreased since vaccination programs began more than 10 years ago.